SGO Journal Club On-Demand- Controversial Topics in Gyn Cancer: The Times, They Are A-changing – Updates in cervical cancer therapies
Expert panelists will review KEYNOTE-826 to discuss the role of pembrolizumab and the inclusion of bevacizumab, as well as the combination of immunotherapy and radiation in the GOG-9929 trial.
- Clinical Practice
An updated edition of SGO’s handbook reviewing systemic therapy for gynecologic cancer.
- Allied Health Professionals
- Targeted Therapy